Xinghuan Wang to Coronavirus Infections
This is a "connection" page, showing publications Xinghuan Wang has written about Coronavirus Infections.
Connection Strength
0.399
-
Low prevalence of IgG antibodies to SARS-CoV-2 in cancer patients with COVID-19. Int J Cancer. 2020 12 01; 147(11):3267-3269.
Score: 0.028
-
Super-factors associated with transmission of occupational COVID-19 infection among healthcare staff in Wuhan, China. J Hosp Infect. 2020 Sep; 106(1):25-34.
Score: 0.028
-
Reply to Peng He, Xiaohui Wang, and Hao Li's Letter to the Editor re: Yu Xiao, Kaiyu Qian, Yongwen Luo, et al. Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Renal Failure Patients: A Potential Covert Source of Infection. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.03.025. Eur Urol. 2020 11; 78(5):e203-e204.
Score: 0.028
-
Perceived infection transmission routes, infection control practices, psychosocial changes, and management of COVID-19 infected healthcare workers in a tertiary acute care hospital in Wuhan: a cross-sectional survey. Mil Med Res. 2020 05 11; 7(1):24.
Score: 0.028
-
Family cluster of three recovered cases of pneumonia due to severe acute respiratory syndrome coronavirus 2 infection. BMJ Case Rep. 2020 May 04; 13(5).
Score: 0.028
-
Environmental contamination of SARS-CoV-2 in healthcare premises. J Infect. 2020 08; 81(2):e1-e5.
Score: 0.028
-
Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Renal Failure Patients: A Potential Covert Source of Infection. Eur Urol. 2020 Aug; 78(2):298-299.
Score: 0.027
-
Re: Profile of specific antibodies to SARS-CoV-2: The first report. J Infect. 2020 07; 81(1):e80-e81.
Score: 0.027
-
Nosocomial SARS-CoV-2 infection among nurses in Wuhan at a single centre. J Infect. 2020 06; 80(6):e41-e42.
Score: 0.027
-
Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation. J Infect. 2020 05; 80(5):e14-e17.
Score: 0.027
-
Experience of different upper respiratory tract sampling strategies for detection of COVID-19. J Hosp Infect. 2020 05; 105(1):1-2.
Score: 0.027
-
Association between 2019-nCoV transmission and N95 respirator use. J Hosp Infect. 2020 05; 105(1):104-105.
Score: 0.027
-
Novel biomarkers for the prediction of COVID-19 progression a retrospective, multi-center cohort study. Virulence. 2020 12; 11(1):1569-1581.
Score: 0.007
-
Chemoprophylaxis, diagnosis, treatments, and discharge management of COVID-19: An evidence-based clinical practice guideline (updated version). Mil Med Res. 2020 09 04; 7(1):41.
Score: 0.007
-
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet. 2020 08 15; 396(10249):479-488.
Score: 0.007
-
Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020 07 01; 5(7):811-818.
Score: 0.007
-
Measures for preventing nosocomial infection with SARS-CoV-2 in hematology departments. Ann Hematol. 2020 08; 99(8):1933-1938.
Score: 0.007
-
Outcomes of novel coronavirus disease 2019 (COVID-19) infection in 107 patients with cancer from Wuhan, China. Cancer. 2020 09 01; 126(17):4023-4031.
Score: 0.007
-
Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19. Circ Res. 2020 06 05; 126(12):1671-1681.
Score: 0.007
-
Updating the diagnostic criteria of COVID-19 "suspected case" and "confirmed case" is necessary. Mil Med Res. 2020 04 04; 7(1):17.
Score: 0.007
-
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 03 17; 323(11):1061-1069.
Score: 0.007
-
A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil Med Res. 2020 02 06; 7(1):4.
Score: 0.007